TSI Services Acquires China Polypeptide Group by Issuing Common Stock

San Francisco, CA, November 05, 2008 --(PR.com)-- TSI Services, Inc., a Nevada corporation (the “Company”) announced today that it has completed the required capital restructuring and acquisition of China Polypeptide Group, Ltd. (“CPG”). CPG, founded in 1996, is headquartered in Wuhan, Peoples Republic of China. CPG is in the business of developing, producing and selling peptide products for nutritional supplements. CPG currently has 32 sales offices and expects to substantially expand its selling efforts to the Chinese market. CPG’s key products have obtained Chinese regulatory approvals and CPG has two granted patents and three patent applications. CPG’s target market is the aging population, both in China and globally seeking nutritional supplements.

After the acquisition of CPG and the capital restructuring, the Company will have approximately 29 million common shares outstanding. The shareholders of CPG own approximately 27.5 million shares or approximately 95% of the Company. The remaining shares will be held by approximately 220 shareholders. The Company expects to register for trading on a US stock exchange in the near future.

TSI Services, Inc. is a “Shell” company that is principally owned by Baypeak llc, a privately held investment firm headquartered in San Francisco with an affiliate offices in Beijing and Shanghai China. Baypeak sources, develops and executes investment strategies globally, with a particular focus on “going-public” transactions involving profitable operating companies located in Asia.

Forward Looking Statements. Certain matters discussed within this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company’s ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new business and limited capital.

###